{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T07:54:52Z","timestamp":1781942092725,"version":"3.54.5"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,2,29]],"date-time":"2024-02-29T00:00:00Z","timestamp":1709164800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,2,29]],"date-time":"2024-02-29T00:00:00Z","timestamp":1709164800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Retin Vitr"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Toxoplasma gondii causes ocular toxoplasmosis (OT), involving inflammation, scarring, and retinal complications. The OT complications were retinal detachment (RD), and retinal breakage (RB). Surgical interventions like scleral buckling (SB) and vitrectomy are common. Limited understanding exists of the safety and efficacy of surgical management of RD\/RB secondary to OT. Another complication is toxoplasmosis-related macular holes (tMH), with sparse evidence on surgical outcomes. This meta-analysis aims to clarify clinical characteristics, and surgical results, and enhance understanding of RD, RB, and MH secondary to OT.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>PubMed, Cochrane, Embase and Web of Science database were queried for retrospective studies, case series and case reports that provided information on RD, RB and MH associated with OT and reported the outcomes of: (1) Retinal reattachment of RD\/RB and tMH closure; (2) Best-corrected visual acuity (BCVA) improvement; and (3) Complications. Heterogeneity was examined with I<jats:sup>2<\/jats:sup> statistics. A random-effects model was used for outcomes with high heterogeneity. Statistical analysis was performed using the software R (version 4.2.3, R Foundation for Statistical Computing, Vienna, Austria).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Fourteen final studies, comprising a total of 96 patients were analyzed, 81 with RD or RB and 15 with tMH. Overall, surgical management was associated with several advantages: a high rate of retinal reattachment of RD\/RB of 97% (95% Confidence Interval [CI] 92\u2013100%; I<jats:sup>2<\/jats:sup>\u2009=\u20090%), retinal reattachment of just RD of 96% (95% CI 89\u2013100%; I<jats:sup>2<\/jats:sup>\u2009=\u200930%) and tMH closure 97% (95% CI 87\u2013100; I<jats:sup>2<\/jats:sup>\u2009=\u200912%). There were significant differences in BCVA after surgeries in studies of RD\/RB (MD 0.60; 95% CI 0.35\u20130.65; I<jats:sup>2<\/jats:sup>\u2009=\u200920%) and MH (MD 0.67; 95% CI 0.50\u20130.84; I<jats:sup>2<\/jats:sup>\u2009=\u20090%). The overall complication rate associated with surgical procedures in RD\/RB secondary to OT was confirmed to be 25%.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>The systematic review and meta-analysis showed that the treatment approaches currently in use are effective, with a remarkable rate of retinal reattachment of RD\/RB, tMH closure, and substantial improvements in visual acuity. More randomized, long-term studies on disease and surgical factors can provide valuable insights into their impact on anatomical and visual outcomes.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s40942-024-00540-w","type":"journal-article","created":{"date-parts":[[2024,2,29]],"date-time":"2024-02-29T07:02:16Z","timestamp":1709190136000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Surgical management of retinal detachment and macular holes secondary to ocular toxoplasmosis: a systematic review and meta-analysis"],"prefix":"10.1186","volume":"10","author":[{"given":"Dillan Cunha","family":"Amaral","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Lane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo Henrique Cassins","family":"Aguiar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guilherme Nunes","family":"Marques","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luiza Visentin","family":"Cavassani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00e1rcio Penha Morter\u00e1","family":"Rodrigues","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milton Ruiz","family":"Alves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Eduardo Ferreira","family":"Manso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00e1rio Luiz Ribeiro","family":"Monteiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9610-5768","authenticated-orcid":false,"given":"Ricardo Noguera","family":"Louzada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,2,29]]},"reference":[{"issue":"2","key":"540_CR1","doi-asserted-by":"publisher","first-page":"91","DOI":"10.3109\/09273948.2011.564068","volume":"19","author":"E Delair","year":"2011","unstructured":"Delair E, Latkany P, Noble AG, Rabiah P, McLeod R, Br\u00e9zin A. Clinical manifestations of ocular toxoplasmosis. Ocul Immunol Inflamm. 2011;19(2):91\u2013102.","journal-title":"Ocul Immunol Inflamm"},{"issue":"4","key":"540_CR2","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1007\/s10384-003-0069-0","volume":"48","author":"LS Atmaca","year":"2004","unstructured":"Atmaca LS, Simsek T, Batioglu F. Clinical features and prognosis in ocular toxoplasmosis. Jpn J Ophthalmol. 2004;48(4):386\u201391.","journal-title":"Jpn J Ophthalmol"},{"issue":"1","key":"540_CR3","first-page":"CD007417","volume":"1","author":"S Jasper","year":"2017","unstructured":"Jasper S, Vedula SS, John SS, Horo S, Sepah YJ, Nguyen QD. Corticosteroids as adjuvant therapy for ocular toxoplasmosis. Cochrane Database Syst Rev. 2017;1(1):CD007417.","journal-title":"Cochrane Database Syst Rev"},{"issue":"8","key":"540_CR4","doi-asserted-by":"publisher","first-page":"2597","DOI":"10.1007\/s00436-018-5950-3","volume":"117","author":"HB Song","year":"2018","unstructured":"Song HB, Jung BK, Kim JH, Lee YH, Choi MH. Investigation of tissue cysts in the retina in a mouse model of ocular toxoplasmosis: distribution and interaction with glial cells. Parasitol Res. 2018;117(8):2597\u2013605.","journal-title":"Parasitol Res"},{"issue":"6","key":"540_CR5","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1136\/bjo.2007.133314","volume":"92","author":"DO Zamora","year":"2008","unstructured":"Zamora DO, Rosenbaum JT, Smith JR. Invasion of human retinal vascular endothelial cells by Toxoplasma gondii tachyzoites. Br J Ophthalmol. 2008;92(6):852\u20135.","journal-title":"Br J Ophthalmol"},{"issue":"4","key":"540_CR6","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1046\/j.1365-3083.2002.01052.x","volume":"55","author":"AL Vallochi","year":"2002","unstructured":"Vallochi AL, Nakamura MV, Schlesinger D, Martins MC, Silveira C, Belfort R, et al. Ocular toxoplasmosis: more than just what meets the eye. Scand J Immunol. 2002;55(4):324\u20138.","journal-title":"Scand J Immunol"},{"issue":"6","key":"540_CR7","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1016\/j.ajo.2003.09.040","volume":"136","author":"GN Holland","year":"2003","unstructured":"Holland GN. Ocular toxoplasmosis: a global reassessment. Part I: epidemiology and course of disease. Am J Ophthalmol. 2003;136(6):973\u201388.","journal-title":"Am J Ophthalmol"},{"issue":"4","key":"540_CR8","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1038\/sj.eye.6700197","volume":"16","author":"NG Ghazi","year":"2002","unstructured":"Ghazi NG, Green WR. Pathology and pathogenesis of retinal detachment. Eye (Lond). 2002;16(4):411\u201321.","journal-title":"Eye (Lond)"},{"issue":"3","key":"540_CR9","first-page":"CD009562","volume":"3","author":"L Znaor","year":"2019","unstructured":"Znaor L, Medic A, Binder S, Vucinovic A, Marin Lovric J, Puljak L. Pars plana vitrectomy versus scleral buckling for repairing simple rhegmatogenous retinal detachments. Cochrane Database Syst Rev. 2019;3(3):CD009562.","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"540_CR10","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/j.ophtha.2018.11.014","volume":"126","author":"RJ Hillier","year":"2019","unstructured":"Hillier RJ, Felfeli T, Berger AR, Wong DT, Altomare F, Dai D, et al. The pneumatic retinopexy versus vitrectomy for the management of primary rhegmatogenous retinal detachment outcomes randomized trial (PIVOT). Ophthalmology. 2019;126(4):531\u20139.","journal-title":"Ophthalmology"},{"key":"540_CR11","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71.","journal-title":"BMJ"},{"issue":"4","key":"540_CR12","doi-asserted-by":"publisher","first-page":"281","DOI":"10.5935\/0004-2749.20180057","volume":"81","author":"FV Moreira","year":"2018","unstructured":"Moreira FV, Iwanusk AM, Amaral ARD, N\u00f3brega MJ, Novelli FJ. Surgical outcomes of rhegmatogenous retinal detachment associated with ocular toxoplasmosis. Arq Bras Oftalmol. 2018;81(4):281\u20135.","journal-title":"Arq Bras Oftalmol"},{"issue":"2","key":"540_CR13","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1097\/IAE.0000000000000279","volume":"35","author":"A Faridi","year":"2015","unstructured":"Faridi A, Yeh S, Suhler EB, Smith JR, Flaxel CJ. Retinal detachment associated with ocular toxoplasmosis. Retina. 2015;35(2):358\u201363.","journal-title":"Retina"},{"issue":"1","key":"540_CR14","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/S0161-6420(99)00013-5","volume":"107","author":"LH Bosch-Driessen","year":"2000","unstructured":"Bosch-Driessen LH, Karimi S, Stilma JS, Rothova A. Retinal detachment in ocular toxoplasmosis. Ophthalmology. 2000;107(1):36\u201340.","journal-title":"Ophthalmology"},{"issue":"6","key":"540_CR15","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1177\/112067210901900622","volume":"19","author":"A Adan","year":"2009","unstructured":"Adan A, Giralt J, Alvarez G, Alforja S, Bur\u00e9s-Jesltrup A, Casaroli-Marano RP, et al. Pars plana vitrectomy for vitreoretinal complications of ocular toxoplasmosis. Eur J Ophthalmol. 2009;19(6):1039\u201343.","journal-title":"Eur J Ophthalmol"},{"issue":"2","key":"540_CR16","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1097\/ICB.0000000000000757","volume":"15","author":"DC Sousa","year":"2021","unstructured":"Sousa DC, Andrade GC, Nascimento H, Maia A, Muccioli C. Macular hole associated with toxoplasmosis: a surgical case series. Retin Cases Brief Rep. 2021;15(2):110\u20133.","journal-title":"Retin Cases Brief Rep"},{"key":"540_CR17","doi-asserted-by":"publisher","DOI":"10.1590\/S0004-27492009000600018","author":"D Lucena","year":"2009","unstructured":"Lucena D, Ribeiro A, Lucena D, Lucena A, Jorge R. Roturas retinianas em retinocoroidite por toxoplasmose: s\u00e9rie de casos. Arq Bras De Oftalmol. 2009. https:\/\/doi.org\/10.1590\/S0004-27492009000600018.","journal-title":"Arq Bras De Oftalmol"},{"issue":"Suppl 4","key":"540_CR18","first-page":"84","volume":"16","author":"F Kianersi","year":"2012","unstructured":"Kianersi F, NaderiBeni A, Ghanbari H, Fazel F. Ocular toxoplasmosis and retinal detachment: five case reports. Eur Rev Med Pharmacol Sci. 2012;16(Suppl 4):84\u20139.","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"8","key":"540_CR19","first-page":"4568","volume":"64","author":"H Caplan","year":"2023","unstructured":"Caplan H, Wakabayashi T, Klufas M, Mehta S, Deaner J, Dunn JP, et al. Prevalence, characteristics, and outcomes of retinal detachment associated with toxoplasmosis retinochoroiditis. Investigat Ophthalmol Visual Sci. 2023;64(8):4568.","journal-title":"Investigat Ophthalmol Visual Sci"},{"issue":"4","key":"540_CR20","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1016\/j.jfo.2021.12.004","volume":"45","author":"MK Erol","year":"2022","unstructured":"Erol MK, Bozdogan YC, Suren E, Gedik B. Treatment of a full-thickness macular hole and retinal detachment secondary to toxoplasma chorioretinitis that developed shortly after COVID-19: a case report. J Fr Ophtalmol. 2022;45(4):446\u201351.","journal-title":"J Fr Ophtalmol"},{"issue":"5","key":"540_CR21","doi-asserted-by":"publisher","first-page":"e115","DOI":"10.1016\/j.jcjo.2014.06.006","volume":"49","author":"R Tanaka","year":"2014","unstructured":"Tanaka R, Obata R, Sawamura H, Ohtomo K, Kaburaki T. Temporal changes in a giant macular hole formed secondary to toxoplasmic retinochoroiditis. Can J Ophthalmol. 2014;49(5):e115\u20138.","journal-title":"Can J Ophthalmol"},{"issue":"1","key":"540_CR22","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1007\/s10792-013-9754-2","volume":"34","author":"B Arana","year":"2014","unstructured":"Arana B, Fonollosa A, Artaraz J, Martinez-Berriotxoa A, Martinez-Alday N. Macular hole secondary to toxoplasmic retinochoroiditis. Int Ophthalmol. 2014;34(1):141\u20133.","journal-title":"Int Ophthalmol"},{"issue":"2","key":"540_CR23","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1159\/000514910","volume":"12","author":"M Ikeda","year":"2021","unstructured":"Ikeda M, Baba T, Aikawa Y, Yotsukura J, Yokouchi H, Yamamoto S. Case of macular hole secondary to ocular toxoplasmosis treated successfully by vitrectomy with inverted internal limiting membrane flap. Case Rep Ophthalmol. 2021;12(2):363\u20138.","journal-title":"Case Rep Ophthalmol"},{"issue":"5","key":"540_CR24","doi-asserted-by":"publisher","first-page":"915","DOI":"10.4103\/ijo.IJO_1262_19","volume":"68","author":"S Doshi","year":"2020","unstructured":"Doshi S, Gulati M, Pathengay A, Hegde S. Spontaneous closure of macular hole in a case of toxoplasma retinochoroiditis. Indian J Ophthalmol. 2020;68(5):915\u20136.","journal-title":"Indian J Ophthalmol"},{"key":"540_CR25","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.ajoc.2018.03.007","volume":"10","author":"NL Scott","year":"2018","unstructured":"Scott NL, Sridhar J, Flynn HW. Management of giant retinal tear and retinal detachment in a patient with active toxoplasmosis retinochoroiditis. Am J Ophthalmol Case Rep. 2018;10:226\u20138.","journal-title":"Am J Ophthalmol Case Rep"},{"issue":"6","key":"540_CR26","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1016\/j.ajo.2008.09.006","volume":"146","author":"EM Dodds","year":"2008","unstructured":"Dodds EM, Holland GN, Stanford MR, Yu F, Siu WO, Shah KH, et al. Intraocular inflammation associated with ocular toxoplasmosis: relationships at initial examination. Am J Ophthalmol. 2008;146(6):856-65.e2.","journal-title":"Am J Ophthalmol"},{"issue":"6","key":"540_CR27","doi-asserted-by":"publisher","first-page":"811","DOI":"10.5301\/EJO.2011.6403","volume":"21","author":"NJ London","year":"2011","unstructured":"London NJ, Hovakimyan A, Cubillan LD, Siverio CD, Cunningham ET. Prevalence, clinical characteristics, and causes of vision loss in patients with ocular toxoplasmosis. Eur J Ophthalmol. 2011;21(6):811\u20139.","journal-title":"Eur J Ophthalmol"},{"issue":"5","key":"540_CR28","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1016\/S0161-6420(02)00990-9","volume":"109","author":"LE Bosch-Driessen","year":"2002","unstructured":"Bosch-Driessen LE, Berendschot TT, Ongkosuwito JV, Rothova A. Ocular toxoplasmosis: clinical features and prognosis of 154 patients. Ophthalmology. 2002;109(5):869\u201378.","journal-title":"Ophthalmology"},{"issue":"1","key":"540_CR29","first-page":"1","volume":"137","author":"GN Holland","year":"2004","unstructured":"Holland GN. Ocular toxoplasmosis: a global reassessment. Part II: disease manifestations and management. Am J Ophthalmol. 2004;137(1):1\u201317.","journal-title":"Am J Ophthalmol"},{"key":"540_CR30","first-page":"2043","volume":"7","author":"C Iwahashi-Shima","year":"2013","unstructured":"Iwahashi-Shima C, Sato T, Bando H, Ikeda T, Emi K. Anatomic and functional outcomes of 25-gauge vitrectomy for repair of eyes with rhegmatogenous retinal detachment complicated by proliferative vitreoretinopathy. Clin Ophthalmol. 2013;7:2043\u20139.","journal-title":"Clin Ophthalmol"},{"issue":"5","key":"540_CR31","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1038\/eye.2012.20","volume":"26","author":"D Kova\u010devi\u0107-Pavi\u0107evi\u0107","year":"2012","unstructured":"Kova\u010devi\u0107-Pavi\u0107evi\u0107 D, Radosavljevi\u0107 A, Ili\u0107 A, Kova\u010devi\u0107 I, Djurkovi\u0107-Djakovi\u0107 O. Clinical pattern of ocular toxoplasmosis treated in a referral centre in Serbia. Eye (Lond). 2012;26(5):723\u20138.","journal-title":"Eye (Lond)"},{"issue":"1","key":"540_CR32","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/S0002-9394(02)01526-X","volume":"134","author":"GN Holland","year":"2002","unstructured":"Holland GN, Lewis KG. An update on current practices in the management of ocular toxoplasmosis. Am J Ophthalmol. 2002;134(1):102\u201314.","journal-title":"Am J Ophthalmol"},{"key":"540_CR33","doi-asserted-by":"publisher","first-page":"100882","DOI":"10.1016\/j.preteyeres.2020.100882","volume":"81","author":"JR Smith","year":"2021","unstructured":"Smith JR, Ashander LM, Arruda SL, Cordeiro CA, Lie S, Rochet E, et al. Pathogenesis of ocular toxoplasmosis. Prog Retin Eye Res. 2021;81:100882.","journal-title":"Prog Retin Eye Res"},{"issue":"4","key":"540_CR34","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1097\/IIO.0b013e31822d663b","volume":"51","author":"M Englander","year":"2011","unstructured":"Englander M, Young LH. Ocular toxoplasmosis: advances in detection and treatment. Int Ophthalmol Clin. 2011;51(4):13\u201323.","journal-title":"Int Ophthalmol Clin"},{"issue":"8","key":"540_CR35","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1016\/j.ijpara.2009.02.004","volume":"39","author":"LM Weiss","year":"2009","unstructured":"Weiss LM, Dubey JP. Toxoplasmosis: a history of clinical observations. Int J Parasitol. 2009;39(8):895\u2013901.","journal-title":"Int J Parasitol"},{"issue":"3","key":"540_CR36","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1159\/000440679","volume":"6","author":"M Mizuno","year":"2015","unstructured":"Mizuno M, Fujinami K, Watanabe K, Akiyama K. Macular hole associated with Vogt-Koyanagi-harada disease at the acute Uveitic stage. Case Rep Ophthalmol. 2015;6(3):328\u201332.","journal-title":"Case Rep Ophthalmol"}],"container-title":["International Journal of Retina and Vitreous"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40942-024-00540-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40942-024-00540-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40942-024-00540-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,29]],"date-time":"2024-02-29T07:04:59Z","timestamp":1709190299000},"score":1,"resource":{"primary":{"URL":"https:\/\/journalretinavitreous.biomedcentral.com\/articles\/10.1186\/s40942-024-00540-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,29]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["540"],"URL":"https:\/\/doi.org\/10.1186\/s40942-024-00540-w","relation":{},"ISSN":["2056-9920"],"issn-type":[{"value":"2056-9920","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,29]]},"assertion":[{"value":"4 January 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 February 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 February 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"23"}}